KalVista, Biogen, Ionis get EU positive opinions for key drugs

17 hours ago 1
Neuron system disease

koto_feja/E+ via Getty Images

KalVista Pharmaceuticals (NASDAQ:KALV), Biogen (NASDAQ:BIIB), and Ionis Pharmaceuticals (NASDAQ:IONS) announced that the European Medicines Agency (EMA) has given positive endorsements for their products.

The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for KalVista's Sebetralstat, an oral medication

Recommended For You

More Trending News

Read Entire Article